Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:37 AM
Ignite Modification Date:
2025-12-25 @ 3:37 AM
NCT ID:
NCT02980302
Eligibility Criteria:
Inclusion Criteria :
* Patient with an intellectual deficiency and/or associated signs that received a chromosomic analysis by CGH-array revealing a variant of unknown signification involvingone or more genes candidates for mental retardation.
* Certificate of genetic genetic counselling and signed consent.
* Under 18 persons may be necessary because intellectual deficiency is often diagnosed before the adult age.
* Number of cases is very limited in this preliminary study and only one patient showing a rare mutation of MYT1L gene and his father ( asymptomatic carrier of the same mutation) will be study.
* Affiliation to a social security system
Exclusion Criteria :
* Persons mentionned L1121-5 to L1121-8 of CSP (all protected persons)
* Persons suffering from acute infections for the practice of cutaneous biopsy under local anesthesia.
* Persons showing an hemostasis disorder acquired or induced
* Persons sous traitement antiagrégant anticoagulant
* Persons with a mutation in th gene MYT1L
Healthy Volunteers:
True
Sex:
ALL
Study:
NCT02980302
Study Brief:
Protocol Section:
NCT02980302